Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 5, 1996, Pages 533-538

  Gotteland, J P ^a   Delhon, A ^a   Junquero D ^a   Oms, P ^a   Halazy, S ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; ENZYME INHIBITOR; LOW DENSITY LIPOPROTEIN; OXIDOREDUCTASE; PROBUCOL; SILANE DERIVATIVE; SQUALENE MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0029972476     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00063-7     Document Type: Article

References (27)

1. Lipids Research Clinics Program; J. Am. Med. Assoc. 1984, 251, 351-364; ibid 1984, 251, 365-374.
2. Lipids Research Clinics Program; J. Am. Med. Assoc. 1984, 251, 351-364; ibid 1984, 251, 365-374.
3. (a) Partasarathy, S.; Steinberg, D.; Witzum, J.-L. Ann. Rev. Med. 1992, 43, 219-225; Holvoet, P.; Collen, D. FASEB 1994, 8, 1279-1284.
4. (a) Partasarathy, S.; Steinberg, D.; Witzum, J.-L. Ann. Rev. Med. 1992, 43, 219-225; Holvoet, P.; Collen, D. FASEB 1994, 8, 1279-1284.
5. (b) Daugherty, A.; Roselaar, S. Cardiovasc. Res. 1995, 29, 297-311.
6. Brown, M. S.; Goldstein, J. L. Angew. Chem., Int. Ed. Engl. 1986, 25, 583-602.
7. Feussner, G. Current Opinion in Lipidology 1994, 5, 59-68.
8. Abe, I.; Tomesch, J. C.; Wattanasin, S.; Prestwich, G. D. Nat. Prod. Rep. 1994, 11, 279-302.
9. Horie, M.; Sawasaki, Y.; Fukuzumi, H.; Watanabe, K.; Izuka, Y.; Tsuchiya, Y.; Kamei, T. Atherosclerosis 1991, 88, 283-192.
10. Gotteland, J.-P.; Brunel, I.; Gendre, F.; Désiré, J.; Delhon, A.; Junquéro, D.; Oms P.; Halazy, S. J. Med. Chem. 1995, 38, 3207-3216.
11. Jackson, R.L.; Ku, G.; Thomas, C.E. Med Res. Rev. 1993, 2, 161-182.
12. Iwazawa, Y.; Horie, M. Drugs of the Future 1993, 18, 911-918.
13. Gotteland, J.-P.; Halazy, S. manuscript in preparation.
14. Cooper, B. E.; Owen, W. J. J. Organomet. Chem. 1971, 29, 33-40.
15. (a) Silverman, R. B.; Banik, G. M. J. Am. Chem. Soc. 1987, 109, 2219-2220
16. (b) Banik, G. M.; Silverman, R. B. J. Am. Chem. Soc. 1990, 112, 4499-4507
17. (c) Danzin, C.; Collard, J.-N.; Marchal, P.; Schirlin, D. Biochem. Biophys. Res. Commun. 1989, 160, 540-544.
18. 50 values have been determined by measuring the extent of lipid peroxidation by the TBARS method according to Yagi K. Chem. Phys. Lipids 1987, 45, 337-351.
19. 4
20. Stutz, A.; Petranyi, G. J. Med. Chem. 1984, 27, 1539-1543.
21. 39NOSi : C, 77.72 ; H , 9.32 ; N, 6.47. Found : C, 77.58 ; H, 9.12 ; N, 6.35.
22. The microsomal squalene epoxidase activity was assayed according to Bai, M.; Prestwich, G. D. Arch. Biochem. Biophys. 1992, 293, 305-313.
23. 14C acetate incorporation according to Horie, M.; Tsuchiya, Y.; Hayashi, M.; Iida, Y.; Iwasawa, Y.; Nagata, Y.; Sawasaki, Y.; Fukuzumi, H.; Kitani, K.; Kamei, T. J. Biol. Chem. 1990, 265, 18075-18078.
24. Breugnot, C.; Maziere, C.; Salmon, S.; Auclair, M.; Santus, R.; Morliere, P.; Lenaers, A.; Maziere, Z. Biochem. Pharmacol. 1990, 40, 1975-1980.
25. a) Halliwell, B. Drugs 1991, 42, 569-605.
26. b) Bast, A. DN&P 1994, 7, 466-472.
27. c) Maxwell, S. R. Drugs 1995, 49, 345-361.